Joseph Kvedar September 14, 2022
There has been much controversy in the lay press in the last six months or so regarding telehealth as a tool for addressing the behavioral health crisis. Much of the conversation has centered on whether a video consultation with a behavioral health provider is of sufficient quality to allow decision-making regarding prescribing psychiatric medications. There’s also the question of whether or not an in-person visit should be required before a provider can prescribe a controlled substance to a patient, creating a further barrier to care.
Interestingly, as far back as 2005, this was reviewed in a meta-analysis that concluded that telepsychiatry was no different from in-person care in terms of accuracy and satisfaction.
Fast forward to present day, and...
Today's Sponsors
Today's Sponsor